9 results on '"Rodríguez‐García, Yaiza"'
Search Results
2. A model to investigate drug-tolerant persister and resistant cells in melanoma targeted with MAPK inhibitors
- Author
-
Burdiel-Herencia, Valeria, González, I., Benito, L., Rodríguez-García, Yaiza, Lirola, A., Teixidó, Joaquín, and Teixidó, Joaquín
- Abstract
2 p., Introduction The BRAFV600E mutation in melanoma is generally associated with activation of the MAPK/ERK signaling pathway, leading to tumor cell proliferation. Targeted therapy with combined BRAFV600E and MEK inhibitors has improved patient survival, but resistance to this treatment is very frequent and represents a serious clinical challenge. Resistance can be intrinsic or can be based on newly-acquired genetic alterations. Moreover, drug tolerant/persister (DTP) clones arising without genetic changes from tumor cells that adapt and survive the initial phases of therapy, can be another source of resistance. The aim of our study is to characterize the mechanisms of resistance to MAPK-targeted therapy in melanoma., Material and Methods We have used the mouse melanoma YUMM cell model to in vitro and in vivo (C57BL/6 mice) generate cells resistant to combined BRAF and MEK inhibitors. Both putative DTP and resistant cell populations have been selected from the in vitro and in vivo platforms, and cell survival and proliferation, and cell signaling and function are being investigated., Results and Discussions DTP and resistant cells display significant changes in growth and in several signaling properties and transition markers, and potential gene differences are currently examined byRNAseq and their functional implications investigated., Conclusion Our in vitro and in vivo models represent useful platforms to mechanistically study drug adaptation and resistance mechanisms in DTP and resistant melanoma cell populations, as well as a system to assess new inhibitors targeting these populations.
- Published
- 2022
3. ICAP‐1 loss impairs CD8 + thymocyte development and leads to reduced marginal zone B cells in mice
- Author
-
Sevilla‐Movilla, Silvia, primary, Fuentes, Patricia, additional, Rodríguez‐García, Yaiza, additional, Arellano‐Sánchez, Nohemi, additional, Krenn, Peter W., additional, de Val, Soledad Isern, additional, Montero‐Herradón, Sara, additional, García‐Ceca, Javier, additional, Burdiel‐Herencia, Valeria, additional, Gardeta, Sofía R., additional, Aguilera‐Montilla, Noemí, additional, Barrio‐Alonso, Celia, additional, Crainiciuc, Georgiana, additional, Bouvard, Daniel, additional, García‐Pardo, Angeles, additional, Zapata, Agustin G., additional, Hidalgo, Andrés, additional, Fässler, Reinhard, additional, Carrasco, Yolanda R., additional, Toribio, Maria L., additional, and Teixidó, Joaquin, additional
- Published
- 2022
- Full Text
- View/download PDF
4. A model to investigate drug-tolerant persister and resistant cells in melanoma targeted with MAPK inhibitors
- Author
-
Teixidó, Joaquín [0000-0002-3177-4151], Burdiel-Herencia, Valeria, González, I., Benito, L., Rodríguez-García, Yaiza, Lirola, A., Teixidó, Joaquín, Teixidó, Joaquín [0000-0002-3177-4151], Burdiel-Herencia, Valeria, González, I., Benito, L., Rodríguez-García, Yaiza, Lirola, A., and Teixidó, Joaquín
- Abstract
Introduction The BRAFV600E mutation in melanoma is generally associated with activation of the MAPK/ERK signaling pathway, leading to tumor cell proliferation. Targeted therapy with combined BRAFV600E and MEK inhibitors has improved patient survival, but resistance to this treatment is very frequent and represents a serious clinical challenge. Resistance can be intrinsic or can be based on newly-acquired genetic alterations. Moreover, drug tolerant/persister (DTP) clones arising without genetic changes from tumor cells that adapt and survive the initial phases of therapy, can be another source of resistance. The aim of our study is to characterize the mechanisms of resistance to MAPK-targeted therapy in melanoma., Material and Methods We have used the mouse melanoma YUMM cell model to in vitro and in vivo (C57BL/6 mice) generate cells resistant to combined BRAF and MEK inhibitors. Both putative DTP and resistant cell populations have been selected from the in vitro and in vivo platforms, and cell survival and proliferation, and cell signaling and function are being investigated., Results and Discussions DTP and resistant cells display significant changes in growth and in several signaling properties and transition markers, and potential gene differences are currently examined byRNAseq and their functional implications investigated., Conclusion Our in vitro and in vivo models represent useful platforms to mechanistically study drug adaptation and resistance mechanisms in DTP and resistant melanoma cell populations, as well as a system to assess new inhibitors targeting these populations.
- Published
- 2022
5. Diseño de rutas turísticas: itinerarios a pie en Santa Cruz de Tenerife
- Author
-
Rodríguez García, Yaiza Alejandra, Brito Santana, Julio Antonio, and Moreno Pérez, José Andrés
- Subjects
Metaheurísticas ,Búsqueda por entornos variables ,Problemas de Diseño de Itineratios Turísticos ,Problemas de Orientación - Abstract
Este trabajo tiene como objetivo dise˜nar rutas tur´ısticas que se puedan realizar a pie en la ciudad de Santa Cruz de Tenerife considerando las preferencias generales de los turistas. Para resolver este problema se desarrollan y aplican modelos del tipo Orienteering Problem, en particular formulamos y encontramos soluciones utilizando los modelos Orienteering Problem Time Windows y Team Orienteering Problem Time Windows. La metodolog´ıa utilizada para encontrar las soluciones es una metodolog´ıa aproximada, dado que este problema es complejo para encontrar soluciones a partir de un cierto n´umero de puntos de inter´es. As´ı para la experimentaci´on y obtenci´on de resultados se aplica la metaheur´ıstica de B´usqueda por Entornos Variables Descendente, que es una variante de la B´usqueda por Entornos Variables. Los datos provienen del Observatorio de la Sociedad de Desarrollo del Ayuntamiento de Santa Cruz de Tenerife y del ISTAC. Los resultados ser´an diferentes rutas, con diferentes duraciones, que tendr´an como punto de partida la Plaza Espa˜na, y que maximizar´an las preferencias generales de los turistas. The objetive of this work is to design tourist routes that can be done on foot in the city of Santa Cruz of Tenerife considering the general preferences of tourist. To solve this problem, are developed and applied models of the Orienteering Problem type, in particular we formulate and find solutions using the Orienteering Problem with Time Windows and Team Orienteering Problem with Time Windows models. The methodology used to find the solutions is an approximate methodology, since this problem is complex to find solutions from a certain number of points of interest. Thus, for experimentation and obtaining results, the Variable Neighbourhood Descent metaheuristic is applied, which is a variant of the Variable Neighbourhood Search. The data come from the Observatorio de la Sociedad de Desarrollo del Ayuntamiento de Santa Cruz de Tenerife and the ISTAC. The results will be differents routes with differents durations, which will have as their starting point the Plaza Espa˜na, and which will maximize the generals preferences of tourists. Problemas de Dise˜no de Itineratios Tur´ısticos metaheur´ısticas Problemas de Orientaci´on B´usqueda por entornos variables Trip Tourist Design Problem Metaheuristic Orienteering Problem Variable Neighborhood Search
- Published
- 2021
6. ICAP‐1 loss impairs CD8+ thymocyte development and leads to reduced marginal zone B cells in mice.
- Author
-
Sevilla‐Movilla, Silvia, Fuentes, Patricia, Rodríguez‐García, Yaiza, Arellano‐Sánchez, Nohemi, Krenn, Peter W., de Val, Soledad Isern, Montero‐Herradón, Sara, García‐Ceca, Javier, Burdiel‐Herencia, Valeria, Gardeta, Sofía R., Aguilera‐Montilla, Noemí, Barrio‐Alonso, Celia, Crainiciuc, Georgiana, Bouvard, Daniel, García‐Pardo, Angeles, Zapata, Agustin G., Hidalgo, Andrés, Fässler, Reinhard, Carrasco, Yolanda R., and Toribio, Maria L.
- Subjects
B cells ,CELL physiology ,CELL adhesion ,TRANSCRIPTION factors ,THYMOCYTES - Abstract
ICAP‐1 regulates β1‐integrin activation and cell adhesion. Here, we used ICAP‐1‐null mice to study ICAP‐1 potential involvement during immune cell development and function. Integrin α4β1‐dependent adhesion was comparable between ICAP‐1‐null and control thymocytes, but lack of ICAP‐1 caused a defective single‐positive (SP) CD8+ cell generation, thus, unveiling an ICAP‐1 involvement in SP thymocyte development. ICAP‐1 bears a nuclear localization signal and we found it displayed a strong nuclear distribution in thymocytes. Interestingly, there was a direct correlation between the lack of ICAP‐1 and reduced levels in SP CD8+ thymocytes of Runx3, a transcription factor required for CD8+ thymocyte generation. In the spleen, ICAP‐1 was found evenly distributed between cytoplasm and nuclear fractions, and ICAP‐1–/– spleen T and B cells displayed upregulation of α4β1‐mediated adhesion, indicating that ICAP‐1 negatively controls their attachment. Furthermore, CD3+‐ and CD19+‐selected spleen cells from ICAP‐1‐null mice showed reduced proliferation in response to T‐ and B‐cell stimuli, respectively. Finally, loss of ICAP‐1 caused a remarkable decrease in marginal zone B‐ cell frequencies and a moderate increase in follicular B cells. Together, these data unravel an ICAP‐1 involvement in the generation of SP CD8+ thymocytes and in the control of marginal zone B‐cell numbers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
- Author
-
García Ortiz, Almudena, Rodríguez García, Yaiza, Encinas, Jessica, Maroto Martín, Elena, Castellano, Eva, Teixidó, Joaquín, Martínez López, Joaquín, García Ortiz, Almudena, Rodríguez García, Yaiza, Encinas, Jessica, Maroto Martín, Elena, Castellano, Eva, Teixidó, Joaquín, and Martínez López, Joaquín
- Abstract
Multiple myeloma (MM) is a hematologic cancer characterized by clonal proliferation of plasma cells in the bone marrow (BM). The progression, from the early stages of the disease as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) to MM and occasionally extramedullary disease, is drastically affected by the tumor microenvironment (TME). Soluble factors and direct cell–cell interactions regulate MM plasma cell trafficking and homing to the BM niche. Mesenchymal stromal cells, osteoclasts, osteoblasts, myeloid and lymphoid cells present in the BM create a unique milieu that favors MM plasma cell immune evasion and promotes disease progression. Moreover, TME is implicated in malignant cell protection against anti-tumor therapy. This review describes the main cellular and non-cellular components located in the BM, which condition the immunosuppressive environment and lead the MM establishment and progression., Ministerio de Ciencia e Innovación (MICINN), Instituto de Salud Carlos III/ CRIS Foundation, Instituto de Salud Carlos III (ISCIII), Research Institute Hospital 12 de Octubre, Depto. de Medicina, Fac. de Medicina, TRUE, pub
- Published
- 2021
8. The role of tumor microenvironment in multiple myeloma development and progression
- Author
-
Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades (España), Sociedad Española de Hematología y Hemoterapia, García-Ortiz, Almudena, Rodríguez-García, Yaiza, Encinas, Jessica, Maroto-Martín, Elena, Castellano, Eva, Teixidó, Joaquín, Martínez-López, Joaquín, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades (España), Sociedad Española de Hematología y Hemoterapia, García-Ortiz, Almudena, Rodríguez-García, Yaiza, Encinas, Jessica, Maroto-Martín, Elena, Castellano, Eva, Teixidó, Joaquín, and Martínez-López, Joaquín
- Abstract
Multiple myeloma (MM) is a hematologic cancer characterized by clonal proliferation of plasma cells in the bone marrow (BM). The progression, from the early stages of the disease as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) to MM and occasionally extramedullary disease, is drastically affected by the tumor microenvironment (TME). Soluble factors and direct cell–cell interactions regulate MM plasma cell trafficking and homing to the BM niche. Mesenchymal stromal cells, osteoclasts, osteoblasts, myeloid and lymphoid cells present in the BM create a unique milieu that favors MM plasma cell immune evasion and promotes disease progression. Moreover, TME is implicated in malignant cell protection against anti-tumor therapy. This review describes the main cellular and non-cellular components located in the BM, which condition the immunosuppressive environment and lead the MM establishment and progression.
- Published
- 2021
9. The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
- Author
-
García-Ortiz, Almudena, primary, Rodríguez-García, Yaiza, additional, Encinas, Jessica, additional, Maroto-Martín, Elena, additional, Castellano, Eva, additional, Teixidó, Joaquín, additional, and Martínez-López, Joaquín, additional
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.